Navigation Links
Naturopathic Care Proves Beneficial for TMD Pain

the study all 12 outcome measures favored naturopathic medicine.

§ There were statistically significant improvements in Worst Facial Pain for those receiving naturopathic care vs. specialty dental care. Similarly, Average Headache Pain showed near-significant improvement (p=.06).

§ Of the eight secondary measures only the impact of Facial Pain on Social Activities approached significance (p=.10).

Conclusions The results demonstrate that while pain outcomes improved for those undergoing both NM and SDC treatment for TMD, patients undergoing NM care benefited more. The data demonstrate the feasibility of conducting clinical trials using whole system naturopathic medicine, and paves the way for further research in larger samples.

(Source: Newswise)
'"/>




Page: 1 2

Related medicine news :

1. Naturopathic Care and Low Back Pain
2. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
3. Study Proves That MMR Vaccine Is Not Connected To Autistic Babies
4. Pilot Study Proves Home Abortions ‘Safe’
5. Many Nonprescription Cough Medicines Proves Ineffective
6. Less Invasive By Pass Surgery Proves Economical In The Long Run
7. Epidural Mistakes Proves To Be Fatal Blunders
8. Combined Anti-Fever Drug Therapy Proves Unsafe for Childhood Fever
9. Drug Trial Proves Nightmare for British Indian Student
10. Medtronic Device Proves Effective in Parkinson’s Diseas
11. Large Community Spirometry Screening Proves Successful
Post Your Comments:
(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...s a grade of "unsatisfactory" when it comes to dea...des that just a handful of states have made moves ...t disease and cervical cancer.// It also concludes... either too little or nothing at all to expand wom...
...rgy, not just carbohydrates, appear to enhance mem...udy published in the American Journal of Clinical ... on cognition have been well-established by resear...ure dietary protein and fat also improve memory,” ...
... inherited disease in which the body's mucus becom...ctioning. Treatment with new antibiotics now allow...o cure.// New research is moving us slightly close...hat modifies the abnormal gene that causes the dis...
...e replacement therapy appear to restore their cogn... whether hormone replacement therapy (HRT) can pro...ies do believe while others have failed to demonst... therefore of especial interest. They followed a g...
Other Medicine News:
(Date:9/3/2008)...rong Children Studied. Wrong,Conclusions Reached.,...Centers for Disease,Control and Prevention (CDC) s...n the MMR vaccine and autism. The National Autism ...dispel the growing public concern over a,vaccine-a...erning design,and methodology., For years, parent...
(Date:9/3/2008)...gy Research and Education Foundation,s Within Our...ecting, Treating and Understan... first time during its,unprecedented initiative to...n College of Rheumatology Research and Education F...om research funded by the Within Our,Reach: Findin...
(Date:9/3/2008)...cular Disease Awareness Month, CHARLOTTESVILLE, V...als,LLC, a clinical-stage drug-development company...met medical needs, announced today that it has beg...al of its lead drug,candidate trans sodium croceti...he clinicaltrials.gov Website, is investigating TS...
(Date:9/3/2008)...wswire/ -- Panacea Pharmaceuticals,Inc. today ann...7 covering,antibodies against human aspartyl (aspa...man cancer biomarker and therapeutic target. These...he Massachusetts Institute of,Technology (MIT) and...atent,for development of human cancer diagnostics ...
Breaking Medicine Technology:CDC Misses Target With Flawed MMR/Autism Study 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 2Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 4Web will work wonders for the faint hearted 11919 1Web will work wonders for the faint hearted 11919 2The Facts African Americans Need to Know About Colon Cancer 11915 1The Facts African Americans Need to Know About Colon Cancer 11915 2The Facts African Americans Need to Know About Colon Cancer 11915 3The Facts African Americans Need to Know About Colon Cancer 11915 4Joint Commission National Quality Forum Now Accepting Applicants for the 2008 John M Eisenberg Patient Safety and Quality Awards 11911 1Joint Commission National Quality Forum Now Accepting Applicants for the 2008 John M Eisenberg Patient Safety and Quality Awards 11911 2Joint Commission National Quality Forum Now Accepting Applicants for the 2008 John M Eisenberg Patient Safety and Quality Awards 11911 3Assured Pharmacy Consolidates Portland Oregon Pharmacy 3306 1Assured Pharmacy Consolidates Portland Oregon Pharmacy 3306 2Assured Pharmacy Consolidates Portland Oregon Pharmacy 3306 3
... WIRE)--May 1, 2007 - Teva,Pharmaceutical Industri... data from a 36-week, randomized, double-blind,pl... an oral 0.6 mg,dose of laquinimod given daily sig...) disease activity by 38 percent in RRMS,patients ...avorable,trend towards reducing annual relapse rat...
...isease Activity as Measured,by MRI and Relapse --...nc.,(NYSE: DNA) and Biogen Idec, Inc. (Nasdaq: BII...inical study of Rituxan®,(rituximab) in patien...MS) were presented today at the American Academy o... is a therapeutic antibody,that targets and select...
Other Medicine Technology:Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 2Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 3Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 4Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 5Laquinimod, a Novel Oral Compound, Showed Significant Reduction in,Disease Activity in Patients with Relapsing-Remitting Multiple,Sclerosis (RRMS) 6Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 2Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 3Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 4Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 5Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 6
Vannas Capsulotomy scissors angled on flat
Vannas Capsulotomy scissors angled to side
Gills-Vannas Capsulotomy scissors straight
Vannas Capsulotomy scissors straight
Medicine Products: